SI SHOULDER INNOVATIONS, INC.
Q3 2025 10-Q
Filed: Nov 12, 2025Period ending Sep 30, 2025
Health Care
Surgical & Medical Instruments & ApparatusSEC EDGAR SHOULDER INNOVATIONS, INC. (SI) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 12, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New debt amendment risk: Second amendment to Trinity Loan Agreement in July 2025 raises covenant breach default risk on $15M principal
- • Updated financial risk: Net loss $32.6M for nine months ended Sept 30, 2025 vs $11.8M prior year, reflecting higher operating expenses and investment
Quarterly Financial SummaryXBRL
Revenue
$12M
▼ -44.4% QoQ
Net Income
-$9M
▲ +63.4% QoQ
Gross Margin
76.2%
▼ -31bp QoQ
Operating Margin
-65.0%
▼ -1697bp QoQ
Net Margin
-74.3%
▲ +3858bp QoQ
ROE
-5.9%
Total Assets
$178M
EPS (Diluted)
$225.13
▲ +197.0% QoQ
Operating Cash Flow
-$9M
▲ +24.1% QoQ
Source: XBRL data from SHOULDER INNOVATIONS, INC. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on SHOULDER INNOVATIONS, INC.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.